·
San Diego, USA – October 1, 2025 - SeekIn Inc., a leading innovator in liquid biopsy-based cancer diagnostics, today announced the publication of a groundbreaking study in Translational Lung Cancer Research. The study highlights the potential of LungCanSeek, a novel blood test that uses four protein markers and artificial intelligence, to transform lung cancer screening by making early detection both highly effective and cost-efficient for broad populations, including those in low- and middle-income countries.